Nile Therapeutics (NLTX) Announces Exercise of Over-Allotment Option by Underwriters in Recent Offering

Nile Therapeutics, Inc. (Nasdaq: NLTX) today announced that the underwriters of its recently completed public offering of units consisting of common stock and warrants have fully exercised their option to purchase an additional 975,000 units to cover over-allotments. The additional units consisted of an aggregate of 975,000 shares of common stock...

Read More